Jones Financial Companies
EWTX icon

Jones Financial Companies’s Edgewise Therapeutics EWTX Stock Holding History

Jones Financial Companies’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$912 Buy
+22
New +$758 ﹤0.01% 4622
2025
Q2 		– Sell
-32
Closed -$745 – 4067
2025
Q1 		$745 Buy
+32
New +$839 ﹤0.01% 3459

Other funds holding EWTX

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jones Financial Companies's EWTX Position: Q2 2026 in Review

Jones Financial Companies opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 22 shares worth $912. The stake represents ﹤0.01% of the portfolio and ranks #4622 among its holdings. This is a return to the name: Jones Financial Companies previously reported a position in EWTX as recently as Q1 2025.

Jones Financial Companies first reported a position in EWTX in Q1 2025 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Jones Financial Companies held 22 shares of Edgewise Therapeutics worth $912 as of Q2 2026.
  • Edgewise Therapeutics was a new Jones Financial Companies position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4622 holding.
  • Jones Financial Companies first reported a position in Edgewise Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.